Demo Sign up Log In

Regeneron Pharmaceuticals (REGN)

Income Tax Expense

$230.90M

Quarterly · Period ending: Jun 30, 2026 · USD

REGN Income Tax Expense

Latest reported$230.90Mperiod endingJun 30, 2026

Latest reported$230.90Mperiod endingJun 30, 2026

REGN Quarterly Income Tax ($0.00 → $230.90M)

Quarterly income tax expense

High-resolution chart · PNG

REGN income tax expense history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Income Tax Expense — Quarterly (USD)
Period ending	Income Tax Expense (USD)
Jun 30, 2001	-6,545,000
Mar 31, 2001	-623,000
Dec 31, 2000	7,321,000
Sep 30, 2000	-2,802,000
Jun 30, 2000	-2,159,000
Mar 31, 2000	-2,388,000
Dec 31, 1999	1,200,000
Sep 30, 1999	0
Jun 30, 1999	-1,300,000
Mar 31, 1999	-900,000
Dec 31, 1998	0
Sep 30, 1998	-2,100,000
Jun 30, 1998	-1,400,000
Mar 31, 1998	0
Dec 31, 1997	1,300,000
Sep 30, 1997	1,600,000
Jun 30, 1997	1,100,000
Mar 31, 1997	3,500,000
Dec 31, 1996	7,200,000
Sep 30, 1996	8,800,000
Jun 30, 1996	7,500,000
Mar 31, 1996	5,900,000
Dec 31, 1995	10,000,000
Sep 30, 1995	9,200,000
Jun 30, 1995	6,000,000
Mar 31, 1995	3,800,000
Dec 31, 1994	700,000
Sep 30, 1994	300,000
Jun 30, 1994	200,000
Mar 31, 1994	300,000
Dec 31, 1993	300,000
Sep 30, 1993	300,000
Jun 30, 1993	-1,100,000
Mar 31, 1993	100,000
Dec 31, 1992	300,000
Sep 30, 1992	200,000
Jun 30, 1992	200,000
Mar 31, 1992	100,000
Dec 31, 1991	0
Sep 30, 1991	-3,400,000
Jun 30, 1991	-3,200,000
Mar 31, 1991	0
Dec 31, 1990	0
Sep 30, 1990	0
Jun 30, 1990	0
Mar 31, 1990	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.